🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carlos G. Briseño

Amgen (United States)

ORCID: 0000-0002-4159-3864

Also affiliated with Washington University in St. Louis

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication”.

Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication

Immunity(2022)10.1016/j.immuni.2022.05.013

N/A

0DataRank · unranked

115 citations

Giulia Scalisi, Giorgia Manni, Carlos G. Briseño, Prachi Bagadia, Vivek Durai +25 more

Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages

The Journal of Experimental Medicine(2023)10.1084/jem.20221472

N/A

0DataRank · unranked

63 citations

Daniel Lu, Maryam Yousefi, Ashley V. Kroll, Chen Hao Lo, Carlos G. Briseño +12 more

Bcl6 , Irf2 , and Notch2 promote nonclassical monocyte development

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2220853120

N/A

0DataRank · unranked

11 citations

Tiantian Liu, Sun Kyung Kim, Carlos G. Briseño, Katia Georgopoulos, Theresa L. Murphy +2 more